Ads
related to: intrinsic asthma treatment options- Cost & Affordability
Learn About Support Available
To You. Visit The Site.
- Doctor Discussion Guide
Questions To Ask Your Dr About A
Treatment Option That May Help.
- Patient Safety Info
Review Safety Information
For Patients Today.
- Find An Asthma Specialist
Find An Asthma Specialist Near You
To Get Help With Severe Asthma.
- Cost Savings For Patients
You Could Pay As Little As
A $0 Co-Pay. Check Eligibility Now!
- Pre-Filled Pen Guide
Download Resource Guide
For Treatment & Self-Injection Now.
- Cost & Affordability
Search results
Results From The WOW.Com Content Network
Here's what you need to know about every asthma treatment option available to you, from over-the-counter medications to natural remedies, doctor-prescribed medications and more.
Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.
Early-onset atopic asthma is the most common phenotype of asthma in childhood, called intrinsic asthma in the earlier intrinsic/extrinsic classification. Patients with early-onset atopic asthma frequently have a family history of atopy, and are sensitised to common allergens. This phenotype usually responds well to inhaled corticosteroids, and ...
An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...
Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).
With the exception of formoterol, LABAs are not recommended for the treatment of acute asthma exacerbations because of their slower onset of action compared to salbutamol. Their long duration of action is due to the addition of a long lipophilic side-chain that binds to an exosite on adrenergic receptors.
Ads
related to: intrinsic asthma treatment options